These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3290992)

  • 21. Dopamine function in obsessive-compulsive disorder: growth hormone response to apomorphine stimulation.
    Brambilla F; Bellodi L; Perna G; Arancio C; Bertani A
    Biol Psychiatry; 1997 Nov; 42(10):889-97. PubMed ID: 9359974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine electrophysiology of ventral pallidal/substantia innominata neurons: comparison with the dorsal globus pallidus.
    Napier TC; Simson PE; Givens BS
    J Pharmacol Exp Ther; 1991 Jul; 258(1):249-62. PubMed ID: 1677041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Auditory information processing in rat genotypes with different dopaminergic properties.
    de Bruin NM; van Luijtelaar EL; Cools AR; Ellenbroek BA
    Psychopharmacology (Berl); 2001 Jul; 156(2-3):352-9. PubMed ID: 11549235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apomorphine-induced yawning in the rat: influence of fasting and time of day.
    Nasello AG; Tieppo CA; Felicio LF
    Physiol Behav; 1995 May; 57(5):967-71. PubMed ID: 7610151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth hormone and prolactin response to apomorphine in bipolar and unipolar depression.
    McPherson H; Walsh A; Silverstone T
    J Affect Disord; 2003 Sep; 76(1-3):121-5. PubMed ID: 12943941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of sulpiride, an atypical neuroleptic, on apomorphine-induced growth hormone secretion.
    Nair NP; Lal S; Iskandar HI; Etienne P; Wood PL; Guyda H
    Brain Res Bull; 1982 Jun; 8(6):587-91. PubMed ID: 7139355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane): central effects of a new dopamine receptor agonist.
    Arnerić SP; Long JP; Williams M; Goodale DB; Mott J; Lakoski JM; Gebhart GF
    J Pharmacol Exp Ther; 1983 Jan; 224(1):161-70. PubMed ID: 6401334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apomorphine-induced activation of dopamine receptors modulates FGF-2 expression in astrocytic cultures and promotes survival of dopaminergic neurons.
    Li A; Guo H; Luo X; Sheng J; Yang S; Yin Y; Zhou J; Zhou J
    FASEB J; 2006 Jun; 20(8):1263-5. PubMed ID: 16636101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response changes after repeated low apomorphine: dopamine autoreceptor desensitization or learning?
    Nickolson VJ; van Riezen H; van Delft AM
    Psychopharmacology (Berl); 1984; 83(2):188-93. PubMed ID: 6431472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological characteristics of dopamine receptors involved in the dual effect of dopamine agonists on yawning behaviour in rats.
    Protais P; Dubuc I; Costentin J
    Eur J Pharmacol; 1983 Oct; 94(3-4):271-80. PubMed ID: 6140175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pre- and post-synaptic dopaminergic receptors involved in apomorphine-induced yawning.
    Urba-Holmgren R; Holmgren B; Anias J
    Acta Neurobiol Exp (Wars); 1982; 42(2):115-25. PubMed ID: 6891988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Penile erection and yawning induced by dopamine D2-like receptor agonists in rats: influence of strain and contribution of dopamine D2, but not D3 and D4 receptors.
    Depoortère R; Bardin L; Rodrigues M; Abrial E; Aliaga M; Newman-Tancredi A
    Behav Pharmacol; 2009 Jul; 20(4):303-11. PubMed ID: 19584712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5-HT1A receptor agonists prevent in rats the yawning and penile erections induced by direct dopamine agonists.
    Simon P; Guardiola B; Bizot-Espiard J; Schiavi P; Costentin J
    Psychopharmacology (Berl); 1992; 108(1-2):47-50. PubMed ID: 1357709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation by sudden darkness of apomorphine-induced behavioral responses.
    Nasello AG; Sassatani AS; Ferreira FS; Felicio LF; Tieppo CA
    Physiol Behav; 2003 Apr; 78(4-5):521-8. PubMed ID: 12782204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apomorphine-induced blinking and yawning in healthy volunteers.
    Blin O; Masson G; Azulay JP; Fondarai J; Serratrice G
    Br J Clin Pharmacol; 1990 Nov; 30(5):769-73. PubMed ID: 2271377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential responses in central dopaminergic activity induced by apomorphine in IPL nude rat.
    Estrella CR; Bregonzio C; Cabrera RJ
    Behav Brain Res; 2002 Jul; 133(2):143-8. PubMed ID: 12110447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions between endogenous dopamine and dopamine agonists at release modulatory receptors: multiple effects of neuronal uptake inhibitors on transmitter release.
    Hoffmann IS; Talmaciu RK; Cubeddu LX
    J Pharmacol Exp Ther; 1986 Aug; 238(2):437-46. PubMed ID: 2942676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heritable differences in the dopaminergic regulation of sensorimotor gating. II. Temporal, pharmacologic and generational analyses of apomorphine effects on prepulse inhibition.
    Swerdlow NR; Shoemaker JM; Auerbach PP; Pitcher L; Goins J; Platten A
    Psychopharmacology (Berl); 2004 Aug; 174(4):452-62. PubMed ID: 15300359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced dopaminergic function in alcoholics is related to severe dependence.
    Schmidt LG; Dettling M; Graef KJ; Heinz A; Kuhn S; Podschus J; Rommelspacher H
    Biol Psychiatry; 1996 Feb; 39(3):193-8. PubMed ID: 8837980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Divergent prolactin and pituitary-adrenal activity in rats selectively bred for different dopamine responsiveness.
    Rots NY; Cools AR; Oitzl MS; de Jong J; Sutanto W; de Kloet ER
    Endocrinology; 1996 May; 137(5):1678-86. PubMed ID: 8612501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.